Delivery Order SPE2D019D0002-SPE2D326F0435
- Not listed
- The Harvard Drug Group, L.L.C., a Native Hawaiian Organization-owned pharmaceutical distributor and subsidiary of Cardinal Health, Inc., was awarded a delivery order on August 20, 2025, by the Medical Supply Chain (an alternate name for Defense Logistics Agency Troop Support Medical) for the supply of Ibuprofen 800 mg tablets in quantities of 500 units. This firm fixed-price delivery order carries a ceiling value of $1,787.80 and an ultimate completion date of August 25, 2025. The performance...
- The Harvard Drug Group, L.L.C., a Native Hawaiian Organization-owned pharmaceutical and medical supply company and subsidiary of Cardinal Health, Inc., was awarded a delivery order contract by the Defense Logistics Agency's Medical Supply Chain on September 19, 2025, for the supply of Mucus Relief ER 600 mg tablets (500 count). This firm fixed-price delivery order carries a ceiling value of $1,084.50 with an ultimate completion date of September 22, 2025, and was awarded without any small...
- The Defense Logistics Agency Troop Support Medical awarded a $2.36 million firm fixed price delivery order contract to The Harvard Drug Group, L.L.C. Major Pharmaceuticals & Rugby Laboratories Division for the supply of 4561749903 acetaminophen 325 mg tablets packaged in quantities of 100 tablets. Performance will take place in Livonia, Michigan over a period of three days from August 7-10, 2023. The prime contractor, The Harvard Drug Group, is a division of Cardinal Health, Inc. The Defense...
- The Defense Logistics Agency Troop Support Medical awarded a $29,840 firm fixed price delivery order contract to The Harvard Drug Group, L.L.C. Major Pharmaceuticals & Rugby Laboratories Division for the supply of 1,000 bottles of 325mg acetaminophen tablets. Performance will take place in Livonia, Michigan over a period of four days from September 26 to 29, 2023. The prime contractor, The Harvard Drug Group, is a division of Cardinal Health, Inc. The delivery order was issued against the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to The Harvard Drug Group, L.L.C. (The Harvard Drug Group), a subsidiary of Cardinal Health, Inc. The $22,590.14 firm-fixed-price contract is for the supply of other medical products, with an ultimate completion date of January 3, 2023. The Harvard Drug Group is a leading provider of pharmaceutical products and medical supplies to the U.S. military, Department of Veterans Affairs, and other government...
- The Defense Logistics Agency Troop Support Medical awarded a $9,440 firm fixed price delivery order contract to The Harvard Drug Group, L.L.C. Major Pharmaceuticals & Rugby Laboratories Division for the supply of 4561406615 acetaminophen 325 mg tablets. Performance will take place in Livonia, Michigan over a period of four days from July 3 through July 7, 2023. The prime contractor, a subsidiary of Cardinal Health, Inc., will deliver the requested pharmaceutical product to the agency. No...
- The Defense Logistics Agency Troop Support Medical awarded a $4,720 delivery order to The Harvard Drug Group, L.L.C. Major Pharmaceuticals & Rugby Laboratories Division for the supply of 100 count bottles of 325mg acetaminophen tablets. The place of performance will be the contractor's facility located in Livonia, Michigan. The firm fixed price order is for delivery between September 19-22, 2023. Cardinal Health, Inc. is the parent company of the prime contractor. No subcontractors or set...
- The U.S. Department of Defense's Medical Supply Chain agency awarded a $1,656.00 firm fixed price delivery order contract to The Harvard Drug Group, L.L.C. to deliver 4563962648 MUCUS RLF DM ER 600-30 MG TAB 20S. This award was made under an unrestricted indefinite delivery, indefinite quantity (IDIQ) contract vehicle managed by the Defense Logistics Agency Troop Support Medical. The Harvard Drug Group is a subsidiary of Cardinal Health, Inc. and a leading provider of pharmaceutical products and...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 4,568,435,704 tablets of 325 mg acetaminophen and has a ceiling value of $2,766.10. The award date is June 3, 2025, and the ultimate completion date is June 4, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp is the...
- The federal contract award SPE2DX15D0004|SPE2DX24F1D13 is for the delivery of pharmaceutical products and medical supplies to the U.S. government's Medical Supply Chain, which is part of the Defense Logistics Agency (DLA). The prime contractor is Cardinal Health, Inc., a global healthcare services and products company. The contract has a ceiling value of $6,654.93 and is a firm fixed-price delivery order contract type, with no set-aside designation. Cardinal Health has a long-standing...
- SPE2D019D0002Indefinite Delivery Contract
- SPE2D019D0002-SPE2D326F0435Delivery Order
The Harvard Drug Group, L.L.C., a Native Hawaiian Organization-owned pharmaceutical distributor and subsidiary of Cardinal Health, Inc., was awarded a delivery order contract by the Defense Logistics Agency's Medical Supply Chain on October 8, 2025, for the supply of acetaminophen 500 mg tablets in quantities of 1,000 units. This firm fixed-price delivery order carries a ceiling value of $1,136.52 and is scheduled for ultimate completion by October 9, 2025. The contract utilizes no small business set-aside designation and represents part of the company's ongoing pharmaceutical supply relationship with federal defense and medical logistics operations. The Harvard Drug Group is headquartered in La Vergne, Tennessee, which also serves as the place of performance for this order. This delivery order leverages The Harvard Drug Group's existing Federal Supply Schedule contract with the Department of Veterans Affairs National Acquisition Center for Drugs, Pharmaceuticals, and Hematology Related Products, which carries a substantially larger ceiling value of $420.1 million through May 31, 2030. The company's positioning as a critical pharmaceutical vendor enables it to provide essential over-the-counter medications and medical consumables across federal healthcare infrastructure, including military, veterans, and civilian medical supply chains. The relatively short delivery window indicates this order addresses immediate operational requirements within the Defense Logistics Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 10/8/25 |